tiprankstipranks
Trending News
More News >
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
US Market
Advertisement

Akebia Therapeutics (AKBA) Technical Analysis

Compare
1,506 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Akebia Therapeutics’s (AKBA) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting Akebia Therapeutics is a Buy.
Akebia Therapeutics’s (AKBA) 20-Day exponential moving average is 2.91, while Akebia Therapeutics’s (AKBA) share price is $2.74, making it a Sell.
Akebia Therapeutics’s (AKBA) 50-Day exponential moving average is 3.10, while Akebia Therapeutics’s (AKBA) share price is $2.74, making it a Sell.

Akebia Therapeutics (AKBA) Pivot Points

Sep 28, 2025, 09:47 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.58
2.64
2.67
2.73
2.76
2.82
2.85
Fibonacci
2.64
2.67
2.69
2.73
2.76
2.78
2.82
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akebia Therapeutics (AKBA) Moving Averages

Sep 28, 2025, 09:47 PM
Period
Simple
Exponential
MA5
2.77Sell
2.77Sell
MA10
2.82Sell
2.82Sell
MA20
2.93Sell
2.91Sell
MA50
3.24Sell
3.10Sell
MA100
3.29Sell
3.06Sell
MA200
2.65Buy
2.62Buy
Akebia Therapeutics’s (AKBA) 10-Day exponential moving average is 2.82, while Akebia Therapeutics’s (AKBA) share price is $2.74, making it a Sell.
Akebia Therapeutics’s (AKBA) 100-Day exponential moving average is 3.06, while Akebia Therapeutics’s (AKBA) share price is $2.74, making it a Sell.
Akebia Therapeutics’s (AKBA) stock price is $2.74 and Akebia Therapeutics’s (AKBA) 50-day simple moving average is 3.24, creating a Sell signal.
Akebia Therapeutics’s (AKBA) stock price is $2.74 and Akebia Therapeutics’s (AKBA) 100-day simple moving average is 3.29, creating a Sell signal.
Akebia Therapeutics’s (AKBA) stock price is $2.74 and Akebia Therapeutics’s (AKBA) 200-day simple moving average is 2.65, creating a Buy signal.

Akebia Therapeutics (AKBA) Technical Indicators

Sep 28, 2025, 09:47 PM
Name
Value
Implied Action
RSI (14)
37.67
Neutral
STOCH (9,6)
12.70
Buy
STOCHRSI (14)
8.60
Buy
MACD (12,26)
-0.13
Buy
ADX (14)
25.32
Neutral
Williams %R
-85.87
Buy
CCI (14)
-135.03
Buy
ATR (14)
0.13
-
Ultimate Oscillator
40.66
Neutral
ROC
-12.46
Sell
Akebia Therapeutics’s (AKBA) Relative Strength Index (RSI) is 37.67, creating a Neutral signal.
Akebia Therapeutics’s (AKBA) Trend Strength Indicator (ADX) is 25.32, creating a Neutral signal.
Akebia Therapeutics’s (AKBA) Commodity Channel Index (CCI) is -135.03, creating a Buy signal.
Akebia Therapeutics’s (AKBA) Price Rate of Change (ROC) is -12.46, creating a Sell signal.

FAQ

Is AKBA a Buy, Hold, or Sell?
Based on AKBA’s technical indicators, AKBA is a Sell.
    What is AKBA’s RSI (14)?
    AKBA’s RSI (14) is 37.67, which suggests AKBA is a Neutral.
      What is AKBA’s MACD?
      AKBA’s MACD is -0.13, which suggests AKBA is a Buy.
        What is AKBA’s 5-day moving average?
        AKBA’s 5-day moving average is 2.77, which suggests AKBA is a Sell.
          What is AKBA’s 20-day moving average?
          AKBA 20-day moving average is 2.93, which suggests AKBA is a Sell.
            What is AKBA’s 50-day moving average?
            AKBA’s 50-day moving average is 3.24, which suggests AKBA is a Sell.
              What is AKBA’s 200-day moving average?
              AKBA’s 200-day moving average is 2.65, which suggests AKBA is a Buy.
                What is AKBA’s Williams % R (14)?
                AKBA’s Williams % R (14) is -85.87, which suggests AKBA is a Buy.
                  What is AKBA’s CCI (14)?
                  AKBA’s CCI (14) is -135.03, which suggests AKBA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis